Trial intelligence / Profile preview

Recombinant ESAT6-CFP10 Allergen Safety and Diagnostic Performance in Healthy Adults and Pulmonary Tuberculosis Patients

CTR20140199Phase 2Completed

Sponsor
Anhui Zhifei Longcom Biopharmaceutical
Start
Apr 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of C-Tb in Tuberculosis (TB), sponsored by Anhui Zhifei Longcom Biopharmaceutical. Started Apr 2014; status: completed.

02

Drugs

C-Tb
03

Conditions

Tuberculosis (TB)

Beyond the preview

Go deeper on CTR20140199.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140199.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call